ClinicalTrials.gov record
Not yet recruiting Phase 1 Interventional

A Randomized Trial of Bicalutamide in Non-Muscle Invasive Bladder Cancer

ClinicalTrials.gov ID: NCT05521698

Public ClinicalTrials.gov record NCT05521698. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 10:35 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT05521698
Recruitment status
Not yet recruiting
Study type
Interventional
Phase
Phase 1
Lead sponsor
University of Wisconsin, Madison
Other
Enrollment
80 participants

Conditions and interventions

Interventions

  • Bicalutamide Drug
  • Biopsy Procedure Procedure
  • Biospecimen Collection Procedure
  • Questionnaire Administration Other
  • Transurethral Resection of Bladder Tumor Procedure

Drug · Procedure · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2026
Primary completion
May 31, 2028
Completion
Nov 30, 2028
Last update posted
Apr 27, 2026

2026 – 2028

United States locations

U.S. sites
6
U.S. states
6
U.S. cities
6
Facility City State ZIP Site status
University of Arizona Cancer Center - Prevention Research Clinic Tucson Arizona 85719
Cedars Sinai Medical Center Los Angeles California 90048
National Cancer Institute Urologic Oncology Branch Bethesda Maryland 20892
University of Rochester Rochester New York 14642
Ohio State University Comprehensive Cancer Center Columbus Ohio 43210
University of Wisconsin Carbone Cancer Center - University Hospital Madison Wisconsin 53792

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05521698, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 27, 2026 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05521698 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →